The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10062 malaria professionals are enjoying the free benefits of MalariaWorld today

artemisinin resistance

An improved nucleic acid extraction method from dried blood spots for amplification of Plasmodium falciparum kelch13 for detection of artemisinin resistance

June 11, 2019 - 14:40 -- Open Access
Tags: 
Author(s): 
Kayvan Zainabadi, Myaing M. Nyunt and Christopher V. Plowe
Reference: 
Malaria Journal 2019 18:192, 11 June 2019

Mutational analysis of the Plasmodium falciparum kelch 13 (k13) gene is routinely performed to track the emergence and spread of artemisinin resistance. Surveillance of resistance markers has been impeded by the difficulty of extracting sufficient DNA from low parasite density infections common in low-transmission settings, such as Southeast Asia. This problem can be overcome by collecting large volumes of venous blood. Efficient methods for extracting and amplifying k13 from dried blood spots (DBS) would facilitate resistance surveillance.

Medical Condition: 

Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines

March 26, 2019 - 15:50 -- Open Access
Author(s): 
Andreas Masch, Abed Nasereddin, Conrad Kunick, et al.
Reference: 
Malaria Journal 2019 18:89, 21 March 2019

The attachment of alkylamino side chains leads to the improvement of antiplasmodial activity and aqueous solubility of selective PfGSK-inhibitors belonging to the class of 4-phenylthieno[2,3-b]pyridines.

Medical Condition: 

NOT Open Access | Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine

March 28, 2018 - 15:36 -- NOT Open Access
Author(s): 
Angana Mukherjee, Dominic Gagnon, Dyann F. Wirth and Dave Richard
Reference: 
Antimicrob. Agents Chemother. April 2018 vol. 62 no. 4 e02309-17

Dihydroartemisinin-piperaquine (DHA-PPQ), the current frontline artemisinin combination therapy used to treat Plasmodium falciparum malaria in multiple Southeast Asian countries, is now increasingly failing in Cambodia, where artemisinin resistance is nearly fixed, which suggests that PPQ resistance has emerged and is spreading rapidly in the Greater Mekong Subregion.

Medical Condition: 
Medical Treatment: 

Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia

December 19, 2017 - 15:26 -- Open Access
Author(s): 
Ankit Dwivedi, Christelle Reynes, Emmanuel Cornillot, et al.
Reference: 
Malaria Journal 2017 16:493, 19 December 2017

Functional analysis of artemisinin resistance subpopulations illustrates the strong interplay between ubiquitination and cell division or differentiation in artemisinin resistant parasites.

Medical Condition: 

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia

May 16, 2017 - 14:58 -- Open Access
Author(s): 
Angana Mukherjee, Selina Bopp, Sarah K. Volkman, et al.
Reference: 
Malaria Journal 2017 16:195, 12 May 2017

This study of 68 culture-adapted Plasmodium falciparum clinical isolates from Cambodia with known clearance values, associated the D584V PfKelch13 mutation with increased ring-stage survival and identified parasites that lack pfkelch13 mutations yet exhibit increased ring-stage survival.

Medical Condition: 

Therapeutic efficacy and artemisinin resistance in northern Myanmar: evidence from in vivo and molecular marker studies

April 11, 2017 - 15:50 -- Open Access
Tags: 
Author(s): 
Moe Kyaw Myint, Charlotte Rasmussen, Aung Thi, Dorina Bustos, Pascal Ringwald and Khin Lin
Reference: 
Malaria Journal 2017 16:143, 7 April 2017

The efficacy of AL, AS + MQ and DP remains high in northern Myanmar despite widespread evidence of k13 mutations associated with delayed parasite clearance.

Country: 
Medical Condition: 

Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015

February 9, 2017 - 14:47 -- Open Access
Author(s): 
Mateusz M. Plucinski, Pedro Rafael Dimbu, Filomeno Fortes, et al.
Reference: 
Malaria Journal 2017 16:62, 2 February 2017

No evidence was found to corroborate the specific allegation of artemisinin resistance in Lunda Sul.

Medical Condition: 

Emerging polymorphisms in falciparum Kelch 13 gene in Northeastern region of India

December 7, 2016 - 17:30 -- Open Access
Tags: 
Author(s): 
Neelima Mishra, Ram Suresh Bharti, Neena Valecha, et al.
Reference: 
Malaria Journal 2016 15:583, 3 December 2016

This is the first study to document the presence of F446I NS mutation in the k13 propeller region from Changlang district, Arunachal Pradesh, a site adjoining the Indo-Myanmar border region, where this mutation is highly prevalent.

Country: 
Medical Condition: 

Plasmodium falciparum: multifaceted resistance to artemisinins

March 15, 2016 - 17:36 -- Open Access
Author(s): 
Lucie Paloque, Arba P. Ramadani, Odile Mercereau-Puijalon, Jean-Michel Augereau and Françoise Benoit-Vical
Reference: 
Malaria Journal 2016 15:149, 9 March 2016

Plasmodium falciparum resistance to artemisinins, the most potent and fastest acting anti-malarials, threatens malaria elimination strategies.

Medical Condition: 

Defining the In Vivo Phenotype of Artemisinin-Resistant Falciparum Malaria: A Modelling Approach

April 30, 2015 - 12:53 -- Open Access
Author(s): 
Lisa J. White, Jennifer A. Flegg, Arjen M. Dondorp, et al.
Reference: 
PLoS Med 12(4): e1001823

Characterisation of overlapping distributions of parasite half-lives provides quantitative insight into the relationship between parasite clearance and artemisinin resistance, as well as the predictive value of the 10% cut-off in 'day-3' parasitaemia.

Medical Condition: 

Pages

Subscribe to RSS - artemisinin resistance